Zimmer Biomet Holdings, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 8 →InsidersNo open-market buys. 2 insiders sold $760,555, 0 of 4 sales on a 10b5-1 plan.→Financing →PeersClosest companies: TFX, SYK, BSX→
From the filings
Figures
- Revenue
- $8.51Blast 12 months
- Net income
- $806.6Mlast 12 months
- Operating cash flow
- $1.67Blast 12 months
- Cash and equivalents
- $410.0Mat the last balance sheet
- Total debt
- $7.48Bat the last balance sheet
- Shares outstanding
- 319.4M shareson issue